AMCP Format for Formulary Submission and eDossier
The evidence requirements contained herein are intended for use by manufacturers of pharmaceuticals, biologics and vaccines who are responding to an unsolicited request from a healthcare system to support reimbursement and/or formulary placement consideration of a new product, new indication, or new formulation of an existing product. Click here for more and to access the resources.
CER Collaborative Toolkit
The CER Collaborative has developed online tools to address the need for real-world understanding and use of the new research being generated - Visit www.CERCollaborative.org.
- AMCP helped to launch the tool to Evaluate Observational Studies for Formulary Coverage Decisions.
- Click here for the details.
CER Collaborative Continuing Education Certificate - The goal of the CER certificate program is to guide pharmacists and other clinical decision-makers by advancing their expertise in assessing evidence that comes from new, unfamiliar research designs, particularly observational research methods, indirect treatment comparisons, modeling, and meta-analyses, making use of the online CER Collaborative tool and resources. Click here to get more information and to enroll.
Good Practices for Outcomes Research - these important papers provide the framework for the Assessing the Evidence: An Individual Study portion of the CER Collaborative’s website.
CER Collaborative Resources and News - Click here to get resources & news (login required).
CER Collaborative Training and Events - Click here for a calendar of upcoming events (login required).
AHRQ CER Resources
CER Glossary of Terms - Click here to view a glossary of terms.
Free online continuing education by AHRQ for pharmacists, physicians and nurses, highlighting findings in comparative effectiveness research.
Click here to view Journal of Managed Care & Specialty Pharmacy articles on CER.